Assoc Prof Ravindran Kanesvaran on how new cancer drug list impacts treatment plans

Measures are in place to continue supporting cancer patients, especially for those being treated with drugs not on a new cancer drug list. Associate Professor Ravindran Kanesvaran, chairperson of the Cancer Treatment Fund Committee, shared more on how the list impacts cancer treatment.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia